✦ LIBER ✦

1469 T1G3 BLADDER CANCER TREATED CONSERVATIVELY WITH BCG OR WITH NO BCG: LONG -TERM FOLLOW UP IN 249 PATIENTS

✍ Scribed by Wehbi, Elias; Bostrom, Peter; Alkhateeb, Sultan; Van Rhijn, Bas; Hanna, Sally; Fleshner, Neil; Finelli, Antonio; Jewett, Michael; Zlotta, Alexandre

Book ID: 123000372
Publisher: Lippincott Williams and Wilkins
Year: 2010
Tongue: English
Weight: 90 KB
Volume: 183
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2010.02.1184

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1353 LOCATION OF TUMORS IN EARLY AND LAT

1353 LOCATION OF TUMORS IN EARLY AND LATE RECURRENCES IN PATIENTS WITH T1G3 BLADDER CANCER TREATED WITH OR WITHOUT BCG: IS THERE ANY DIFFERENCE?

✍ Urdaneta, Guillermo; Palou, Juan; Serrano, Miriam; Parada, Rubén; Rodríguez, Osc 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 84 KB

Disc degeneration in young patients with

Disc degeneration in young patients with isthmic spondylolisthesis treated operatively or conservatively: A long-term follow-up

✍ S. Seitsalo; D. Schlenzka; M. Poussa; K. Österman 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 480 KB

1042 LOCATION OF THE TUMOURS IN EARLY AN

1042 LOCATION OF THE TUMOURS IN EARLY AND LATE RECURRENCES IN PATIENTS WITH T1G3 BLADDER TUMOURS TREATED WITH OR WITHOUT BCG: IS THERE ANY DIFFERENCE?

✍ Urdaneta, G.; Palou, J.; Serrano, M.; Parada, R.; Rodríguez, O.; Gausa, L.; Bred 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 77 KB

1006 17 year follow-up of the Nordic CIS

1006 17 year follow-up of the Nordic CIS study: Long-term results of 1 year BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder

✍ Kaasinen, E.; Wijkström, H.; Malmström, P-U.; Rintala, E.; Jahnsson, S. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 109 KB

MP-19.14: Three year follow-up of a mult

MP-19.14: Three year follow-up of a multicenter trial comparing mitomycin C (MMC) long term with short-term treatment with MMC or Bacillus Calmette-Guerin (BCG) in non muscle-invasive bladder cancer (NMIBC)

✍ M.G. Friedrich; U. Pichlmeier; H. Schwaibold; H. Huland; S. Conrad 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

647 WHAT IS THE LONG TERM PROGNOSTIC VAL

647 WHAT IS THE LONG TERM PROGNOSTIC VALUE OF PROAPOPTOTIC, ANTI-APOPTOTIC, PROLIFERATION AND INVASIVENESS MOLECULAR MARKERS IN PATIENTS TREATED WITH BCG FOR HIGH RISK NON-INVASIVE BLADDER CANCER?

✍ S.S. Alkhateeb; M.G. Neill; B.W. Van Rhijn; D. Kakiashvili; N.E. Fleshner; M.A.S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 505 KB